Formulations and methods for treatment of inflammatory skin diseases

A method of treating inflammatory skin disease in mammals, the method comprising:

• topically applying to the skin of a mammal a topically administrable composition comprising:
• a therapeutic amount of antihistamine selected from the group consisting of a non-sedating antihistamine, a physiologically acceptable acid of a non-sedating antihistamine, a salt of a non-sedating antihistamine, an amide of a non-sedating antihistamine, and a combination of two or more thereof,
• a therapeutic amount of topical corticosteroid, and
• emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination thereof;
• and
• repeating the topical application of the composition as indicated for resolution or control of the skin disease.

A kit for treating inflammatory skin disease in mammals, the kit comprising:

• a first composition, the first composition comprising:
• a therapeutic amount of topical corticosteroid,
• a therapeutic amount of a first antihistamine selected from the group consisting of a first non-sedating antihistamine, a first physiologically acceptable acid of a non-sedating antihistamine, a first salt of a non-sedating antihistamine, a first amide of a non-sedating antihistamine, and a combination of two or more thereof, and
• a first emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination thereof;
• and
• a second composition, the second composition comprising:
• a therapeutic amount of a second antihistamine selected from the group consisting of a second non-sedating antihistamine, a second physiologically acceptable acid of a non-sedating antihistamine, a second salt of a non-sedating antihistamine, a second amide of a non-sedating antihistamine, and a combination of two or more thereof,
• and
• a second emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination thereof.

A method of treating inflammatory skin disease in mammals, the method comprising:

• topically applying to the skin of a mammal a topically administrable first composition comprising:
• a therapeutic amount of a first antihistamine selected from the group consisting of a first non-sedating antihistamine, a first physiologically acceptable acid of a non-sedating antihistamine, a first salt of a non-sedating antihistamine, a first amide of a non-sedating antihistamine, and a combination of two or more thereof,
• a therapeutic amount of topical corticosteroid, and
• a first emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination thereof;
• repeating the topical application of the first composition as indicated for resolution or control of the skin disease;
• topically applying a topically administrable second composition comprising:
• a therapeutic amount of a second antihistamine selected from the group consisting of a second non-sedating antihistamine, a second physiologically acceptable acid of a non-sedating antihistamine, a second salt of a non-sedating antihistamine, a second amide of a non-sedating antihistamine, and a combination of two or more thereof, and
• a second emu oil product selected from the group consisting of emu oil, a biologically active fraction of emu oil, and a combination thereof;
• and
• repeating the topical application of the second composition as indicated for one or more benefits, such benefits selected from the group consisting of control of the skin disease, prevention of recurrence of the skin disease, and avoiding side effects of the first composition.